Description
Folitrax 50mg Injection 2ml is a potent cancer treatment, containing the active ingredient Docetaxel. This injection is designed to slow or stop the growth of certain types of cancer cells, particularly those found in breast, prostate, and non-small cell lung cancer. Each 2ml vial contains 100mg of Docetaxel, providing a 50mg/ml concentration. Administered intravenously under medical supervision, Folitrax plays a crucial role in comprehensive cancer care regimens. Its primary therapeutic use is to manage advanced stages of these specific cancers, improving patient outcomes and quality of life. Always follow your healthcare provider’s instructions for proper usage and dosage.
Reviews
There are no reviews yet.